4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AS BTK INHIBITORS
개요
발명자
Tjeerd A. Barf; Christiaan Gerardus Johannes Maria Jans; Adrianus Petrus Antonius de Man; Arthur A. Oubrie; Hans C.A. Raaijmakers; Johannes Bernardus Maria Rewinkel; Jan Gerard Sterrenburg; Jacobus C.H.M. Wijkmans
IPC 분류
CPC 분류
The present invention relates to 6-5 membered fused pyridine ring compounds according to Formula (I) or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 membered fused pyridine ring compounds according to Formula (I) in the treatment of Bruton's Tyrosine Kinase (Btk) mediated disorders.
원문 (중국어)
The present invention relates to 6-5 membered fused pyridine ring compounds according to Formula (I) or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 membered fused pyridine ring compounds according to Formula (I) in the treatment of Bruton's Tyrosine Kinase (Btk) mediated disorders.